These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4397054)

  • 1. [Clinical testing of a new combination product of a beta blocking agent and a nitroderivative].
    Melli A; Malagù I; Golinelli G; Soffritti A
    Minerva Med; 1970 Sep; 61(78):4271-8. PubMed ID: 4397054
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experience with the association of a beta-blocking agent and pentaerythrite].
    Barbi G; Tallone G
    Minerva Cardioangiol; 1969 Feb; 17(2):139-41. PubMed ID: 5777637
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of coronary insufficiency with beta-adrenergic blocking agents in association with a nitroderivative].
    Rinaldi AR; Zanacchi G
    Minerva Cardioangiol; 1971 Mar; 19(3):160-71. PubMed ID: 4396512
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experiences with a combined preparation (butydrine and pentaerythritol tetranitrate) in coronary insufficiency].
    Chiti E
    Clin Ter; 1970 May; 53(4):315-21. PubMed ID: 4394192
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experimentation with a combination of a beta-blocking agent and a nitro derivative in the prevention of anginous crises and in the basic treatment of coronary insufficiency].
    Borroni G
    Clin Ter; 1970 May; 53(3):247-58. PubMed ID: 4393972
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical evaluation of the therapeutic action of a beta-blocking agent associated with a nitroderivative].
    Salmini G; Cione R; Oldrini R
    Minerva Cardioangiol; 1970 May; 18(5):311-5. PubMed ID: 5515015
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical data on 20 patients treated with the association of butydrine and pentaerythritol tetranitrate].
    Rossi PL; Guarraggi A; Anfossi F
    Clin Ter; 1971 May; 57(4):345-50. PubMed ID: 5110948
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anti-anginal activity of a beta-adrenergic blocking agent, butydrine, alone and in association with pentaerythritol tetranitrate, in the aged].
    Gatti A; Scotti G
    Clin Ter; 1967 May; 41(4):363-74. PubMed ID: 5614306
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical use of a combination of butydrine and pentaerythrol in coronary insufficiency].
    Ballerini A
    Minerva Cardioangiol; 1971 May; 19(5):272-6. PubMed ID: 4397515
    [No Abstract]   [Full Text] [Related]  

  • 10. [Protective effect of a beta-blockador on clinico-electrocardiographic manifestations in the coronary insufficiency apparent during Master's test: description of a clinical case].
    Conti G; Piemontese M; Savarese A; Valva M
    Clin Ter; 1969 Apr; 49(2):181-7. PubMed ID: 4401859
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical evaluation of the effects of beta-adrenergic blocking in heart diseases, with special reference to disorders of rhythm and circulation].
    Fassini G; Saurgnani E; Agliati G; Marangoni R
    Minerva Cardioangiol; 1967 Jan; 15(1):83-122. PubMed ID: 4386133
    [No Abstract]   [Full Text] [Related]  

  • 12. [Renal function and water-electrolyte balance during beta-blocking therapy].
    Bologna E; Bossini A; Puglisi S
    Clin Ter; 1968 Sep; 46(5):457-63. PubMed ID: 4393773
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical evaluation of the beta-adrenergic blocking action of butydrine].
    Nigro G; Comi LI; Limongelli F
    Minerva Cardioangiol; 1968 Dec; 16(12):1267-72. PubMed ID: 5752613
    [No Abstract]   [Full Text] [Related]  

  • 14. [The beta-blocking agents in clinically silent cardiopathies in patients with depressive syndromes].
    De Matteis D
    Minerva Med; 1969 Jan; 60(5):128-39. PubMed ID: 5776761
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical use of the butydrine-pentaetythrite association].
    Ravera M
    Minerva Med; 1968 Oct; 59(86):4561-5. PubMed ID: 5697129
    [No Abstract]   [Full Text] [Related]  

  • 16. [A new beta blocking agent: LB-46. Clinical use in the treatment of rhythm disorders and coronary insufficiency].
    Dutoit A; Lepoutre B; Leuridan B; Croccel L; Giard P
    J Sci Med Lille; 1972 Feb; 90(2):83-9. PubMed ID: 4403207
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study of a prolonged-action coronary vasodilator agent: pentaerythritol tetranitrate].
    Warembourg H; Théry C
    Lille Med; 1966; 11(6):742-5. PubMed ID: 5942195
    [No Abstract]   [Full Text] [Related]  

  • 18. [Coronary therapy with Nitro-Sandolanid].
    Toker Y
    Munch Med Wochenschr; 1970 Apr; 112(17):809-12. PubMed ID: 5467991
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of Peritrate in acute coronary insufficiency].
    Tricot R; Valère P; Castillo A
    Therapeutique; 1971 Nov; 47(9):777-8. PubMed ID: 4947933
    [No Abstract]   [Full Text] [Related]  

  • 20. [Data on the effects of butydrine in patients with coronary insufficiency].
    De Maestri C; Rinaldi AR
    Minerva Cardioangiol; 1969 Feb; 17(2):142-50. PubMed ID: 5777638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.